These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25272198)

  • 41. Erratum: Preparation of Poly(pentafluorophenyl acrylate) Functionalized SiO2 Beads for Protein Purification.
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31038480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central composite rotatable design for optimization of budesonide-loaded cross-linked chitosan-dextran sulfate nanodispersion: characterization,
    Bodas DS; Ige PP
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1193-1204. PubMed ID: 30983428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties.
    de Souza RHFV; Picola IPD; Shi Q; Petrônio MS; Benderdour M; Fernandes JC; Lima AMF; Martins GO; Martinez Junior AM; de Oliveira Tiera VA; Tiera MJ
    Int J Biol Macromol; 2018 Nov; 119():186-197. PubMed ID: 30031084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.
    Cheng W; Tang C; Yin C
    J Gene Med; 2015; 17(10-12):244-56. PubMed ID: 26418829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
    Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.
    He C; Yin L; Tang C; Yin C
    Pharm Res; 2013 Oct; 30(10):2596-606. PubMed ID: 23715740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploration of statistical experimental design to improve entrapment efficiency of acyclovir in poly (d, l) lactide nanoparticles.
    Patel PJ; Gohel MC; Acharya SR
    Pharm Dev Technol; 2014 Mar; 19(2):200-12. PubMed ID: 23432525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
    Chen Y; Sun L; Guo D; Wu Z; Chen W
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
    Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
    Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
    Chaubey P; Patel RR; Mishra B
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer.
    Wang Y; Liu P; Du J; Sun Y; Li F; Duan Y
    J Biomater Sci Polym Ed; 2013; 24(10):1219-32. PubMed ID: 23713424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chitosan-coated nanoliposome as vitamin E carrier.
    Liu N; Park HJ
    J Microencapsul; 2009 May; 26(3):235-42. PubMed ID: 18798045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of apoptosis by chitosan/HPV16 E7 siRNA complexes in cervical cancer cells.
    Yang J; Li S; Guo F; Zhang W; Wang Y; Pan Y
    Mol Med Rep; 2013 Mar; 7(3):998-1002. PubMed ID: 23258711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chitosan glutamate nanoparticles for protein delivery: development and effect on prolidase stability.
    Colonna C; Conti B; Perugini P; Pavanetto F; Modena T; Dorati R; Genta I
    J Microencapsul; 2007 Sep; 24(6):553-64. PubMed ID: 17654175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
    Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
    Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release.
    Shahbazi MA; Hamidi M
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1774-82. PubMed ID: 23136990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Size, Loading Efficiency, and Cytotoxicity of Albumin-Loaded Chitosan Nanoparticles: An Artificial Neural Networks Study.
    Baharifar H; Amani A
    J Pharm Sci; 2017 Jan; 106(1):411-417. PubMed ID: 27866686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
    Gan Q; Wang T
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.